Genevant brings world-class delivery platforms that include best-in-class lipid nanoparticle (LNP) technology and next generation ligand conjugate technology, the industry’s most robust and expansive LNP patent estate, decades of experience and expertise in nucleic acid drug development.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2018
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in